ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Large Decrease in Short Interest

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 400 shares, a drop of 96.0% from the January 31st total of 10,000 shares. Based on an average daily volume of 408,500 shares, the short-interest ratio is currently 0.0 days.

ProtoKinetix Stock Performance

ProtoKinetix stock traded up $0.00 during mid-day trading on Thursday, reaching $0.01. The company’s stock had a trading volume of 241,181 shares, compared to its average volume of 177,778. ProtoKinetix has a twelve month low of $0.01 and a twelve month high of $0.02. The business has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.01.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.